Janssen A M, Bosman C B, Kruidenier L, Griffioen G, Lamers C B, van Krieken J H, van de Velde C J, Verspaget H W
Department of Gastroenterology and Hepatology, Leiden University Medical Center, The Netherlands.
J Cancer Res Clin Oncol. 1999;125(6):327-35. doi: 10.1007/s004320050282.
The oxidant-antioxidant balance within tissues is thought to contribute to the development and progression of cancer. Previous investigations have indicated changes in this balance during the colorectal oncogenic process that merit further investigation. The aim of the present study was to evaluate whether the human colorectal cancer sequence is accompanied by changes in the protein and activity levels of the antioxidant enzymes manganese- and copper/zinc-superoxide dismutase (Mn-SOD and Cu/Zn-SOD).
SOD levels were assessed in colorectal adenomas, carcinomas, and liver metastases and were compared with those in the corresponding normal tissues (n = 35 in each group). Mn- and Cu/Zn-SOD expression was first evaluated semiquantitatively by electrophoretic activity analysis, immunoblotting, and immunohistochemistry and was subsequently quantified by enzyme-linked immunosorbent assays (ELISAs) and spectrophotometric activity assays.
The semiquantitative analyses showed enhanced Mn-SOD levels, primarily localized in (neoplastic) epithelial cells, in carcinomas, and in liver metastases as compared with adenomas and normal mucosa, whereas no consistent pattern was observed for Cu/Zn-SOD. Normal liver tissue expressed the highest levels of both SODs. The quantitative SOD analyses confirmed these observations and revealed that carcinomas and liver metastases expressed 2-4 times more Mn-SOD protein and enzymatic activity (0.0005 < P < 0.01) than did the normal mucosa. Adenomas expressed intermediate Mn-SOD levels, which increased significantly with the diameter and tended to increase with the grade of dysplasia and presence of a villous component. In contrast, adenomas, carcinomas, and the corresponding normal mucosa were found to have a similar Cu/Zn-SOD content, whereas liver metastases contained significantly (P < 0.02) more Cu/Zn-SOD as compared with these tissues. In addition, the Cu/Zn-SOD content was not related to any histopathological characteristic of the carcinomas or adenomas.
Our study indicates that the development of neoplasia in the human colorectum is accompanied by major changes in the level and activity of Mn-SOD. This observation illustrates that Mn-SOD might have a functional role in human colorectal carcinogenesis.
组织内的氧化还原平衡被认为与癌症的发生和发展有关。先前的研究表明,在结直肠癌致癌过程中这种平衡发生了变化,值得进一步研究。本研究的目的是评估人类结直肠癌发生过程中抗氧化酶锰超氧化物歧化酶(Mn-SOD)和铜/锌超氧化物歧化酶(Cu/Zn-SOD)的蛋白质和活性水平是否发生变化。
评估了结直肠腺瘤、癌和肝转移灶中的超氧化物歧化酶(SOD)水平,并与相应正常组织中的水平进行比较(每组n = 35)。首先通过电泳活性分析、免疫印迹和免疫组织化学对Mn-SOD和Cu/Zn-SOD的表达进行半定量评估,随后通过酶联免疫吸附测定(ELISA)和分光光度活性测定进行定量。
半定量分析显示,与腺瘤和正常黏膜相比,癌和肝转移灶中Mn-SOD水平升高,主要定位于(肿瘤)上皮细胞,而Cu/Zn-SOD未观察到一致的模式。正常肝组织中两种SOD的表达水平最高。SOD的定量分析证实了这些观察结果,并显示癌和肝转移灶中Mn-SOD蛋白和酶活性比正常黏膜高2 - 4倍(0.0005 < P < 0.01)。腺瘤中Mn-SOD水平处于中间,随直径显著增加,并随发育异常程度和绒毛成分的存在而有增加趋势。相比之下,腺瘤、癌和相应的正常黏膜中Cu/Zn-SOD含量相似,而肝转移灶中Cu/Zn-SOD含量比这些组织显著更高(P < 0.02)。此外,Cu/Zn-SOD含量与癌或腺瘤的任何组织病理学特征均无关。
我们的研究表明,人类结直肠癌的发生伴随着Mn-SOD水平和活性的重大变化。这一观察结果表明,Mn-SOD可能在人类结直肠癌发生过程中发挥功能性作用。